Closing the Diabetic Loop Before we get into this week’s sector roundup, let’s talk about diabetes. I am a sucker for sweets, so much so that I was diagnosed…
diabetes
Sernova Corp. $435.182M Market Capitaliztion Sernova Corp. (SVA.V) has provided a progress update on the Company’s Phase 1/2 type 1 diabetes (T1D) clinical trial in conjunction with Dr. Piotr…
I have a bit of a sweet tooth. When I was little, my dad used to buy me those massive 64-ounce Jelly Belly containers from Costco. Even that wasn’t…
Diagnos (ADK.V) announced today that it has signed a 7-year contract with Juarez Health & Medical Tourism Cluster (“Cluster”), headquartered in Ciudad Juarez located in the State of Chihuahua,…
In this episode, we talk about DIAGNOS (ADK.V), a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging, and traditional data mining thereby improving decision…
Chris Parry speaks with Andre Larente, president and CEO of DIAGNOS (ADK.V) to get an in-depth look at how their diabetic retinopathy screening services work and what it means…
Diagnos (ADK.V), a leader in early detection announced today that it has signed a pilot in Spain with three franchisees from Opticalia Group. “The campaign begins with the request…
On July 22, 2021 Diagnos (ADK.V) announced the official opening of the initial clinics at the Magrabi Hospital in Saudi Arabia. DIAGNOS specialises in early detection of health problems…
Diagnos (ADK.V) announced today that it has signed a two-month pilot with Hospital Oftalmologico Buena Vista Sinaloa (BVS), the largest ophthalmological hospital in Sinaloa state, Mexico. “Our focus is…
In a world where companies toss the term ‘artificial intelligence’ around whenever the office intern figures out how to get a spreadsheet pie chart to update automatically, it’s nice…